Strategic governance
Provides overall direction, approves priorities and supports long-term institutional development
CABA combines institutional leadership, executive coordination and professional expertise to support accountable decision-making and the development of biotechnology across Central Asia
The Association’s governance model is designed to ensure institutional accountability, cross-sector expertise and effective coordination across Central Asia
CABA’s governance framework brings together strategic oversight, executive implementation and expert advisory mechanisms
Provides overall direction, approves priorities and supports long-term institutional development
Translates strategic priorities into operational programs, partnerships, projects and member services
Engages scientific, industry, investment and international expertise through advisory structures, committees and working groups
CABA brings together institutional leadership and scientific expertise to support the development of the biotechnology ecosystem across Central Asia
Kamalzhan Nadyrov is a healthcare executive and public-sector leader with extensive experience in healthcare management, policy, institutional development and international cooperation. He previously served as Vice Minister of Healthcare of the Republic of Kazakhstan and has held senior leadership positions in national healthcare organizations and medical education.
Vladimir Koykov contributes scientific and institutional development expertise to CABA
Vyacheslav Ogay, PhD, Professor, is a specialist in cellular technologies, regenerative biology and medicine. His scientific work includes stem cells, exosomes, biomaterials, tissue engineering and cell therapy.
CABA is designed as a regional association with representation and cooperation across Central Asia
The regional approach connects biotechnology priorities, professional expertise and cooperation opportunities across Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan and Turkmenistan
Clear responsibilities, transparent decision-making and institutional oversight
Decisions informed by relevant scientific, industry and professional knowledge
Representation of Central Asian priorities and cross-border cooperation
Structured engagement with members, institutions and international partners
Focus on practical initiatives, measurable outcomes and long-term institutional development
CABA welcomes participation from biotechnology leaders, researchers, industry experts, investors, institutions and international partners interested in contributing to the regional biotechnology agenda
CABA’s governance model provides for the General Meeting of Members, the Chair, the Council, the Audit Commission and the Executive Director or Executive Directorate. Together, these roles establish member oversight, strategic direction, control and executive implementation.
Professional competence, integrity and responsibility, independence of judgement, transparency, and prevention and management of conflicts of interest guide decision-making
The model combines scientific, industrial, investment, regulatory and international competencies, prevents dominance by one organization or sector, and supports progressive representation of Central Asian countries
Relevant competencies include biotechnology science and innovation, biotechnology and biopharmaceutical industry, commercialization and technology transfer, entrepreneurship and investment, public policy and regulation, and international cooperation